Intelligent Bio Solutions (INBS) Cash from Investing Activities (2022 - 2024)
Intelligent Bio Solutions has reported Cash from Investing Activities over the past 3 years, most recently at $2551.0 for Q1 2024.
- Quarterly results put Cash from Investing Activities at $2551.0 for Q1 2024, down 98.53% from a year ago — trailing twelve months through Mar 2024 was -$216700.0 (up 82.17% YoY), and the annual figure for FY2023 was -$694142.0, up 21.14%.
- Cash from Investing Activities for Q1 2024 was $2551.0 at Intelligent Bio Solutions, up from -$181750.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for INBS hit a ceiling of $173803.0 in Q1 2023 and a floor of -$703013.0 in Q2 2022.
- Median Cash from Investing Activities over the past 3 years was -$196527.0 (2022), compared with a mean of -$232434.0.
- Biggest five-year swings in Cash from Investing Activities: skyrocketed 74.15% in 2023 and later crashed 98.53% in 2024.
- Intelligent Bio Solutions' Cash from Investing Activities stood at -$211304.0 in 2022, then rose by 13.99% to -$181750.0 in 2023, then surged by 101.4% to $2551.0 in 2024.
- The last three reported values for Cash from Investing Activities were $2551.0 (Q1 2024), -$181750.0 (Q2 2023), and $173803.0 (Q1 2023) per Business Quant data.